Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.50% | 130.67 | 0.7% | $876.22m | |
| PFE | Pfizer Inc. | 0.53% | 36.30 | 0.9% | $660.82m | |
| MRK | Merck & Co., Inc. | 0.40% | 84.68 | 0.7% | $645.76m | |
| ABBV | AbbVie, Inc. | 0.19% | 73.77 | 2.3% | $552.14m | |
| BMY | Bristol-Myers Squibb Company | -0.12% | 51.55 | 1.4% | $505.04m | |
| LLY | Eli Lilly and Company | -0.42% | 107.91 | 1.0% | $305.36m | |
| NVS | Novartis AG Sponsored ADR | -0.77% | 85.93 | 0.2% | $146.48m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.60% | 43.84 | 1.2% | $143.40m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.02% | 42.17 | 0.3% | $93.41m | |
| SNY | Sanofi Sponsored ADR | -0.13% | 44.89 | 0.2% | $80.41m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 1.60% | 52.05 | 0.1% | $71.85m | |
| LCI | Lannett Company, Inc. | -2.17% | 10.82 | 35.6% | $16.01m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -1.65% | 1.79 | 1.6% | $0.58m | |
| EPIX | ESSA Pharma Inc | 0.00% | 3.30 | 0.1% | $0.09m |
Company Profile
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.